Search Results
Sep 01, 2026, 04:00 ET A MANIFESTAÇÃO MAIS SUTIL DO DOMÍNIO DA HUBLOT SOBRE OS MATERIAIS
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar o convencional, o DNA da Hublot é traduzido nos calibre Unico, Meca-10 e turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à Arte
More news about: Hublot SA
Aug 31, 2026, 15:00 ET SKYWORTH Sets New Quality/Performance Benchmark in Premium QD-Mini LED Art TVs with the Introduction of the C2 Canvas Art® TV
a definitive new standard for Art TVs. Rather than lowering our technical specifications to meet the competition, we integrated the advanced display DNA of our flagship CE1 Canvas Elite™ Art TV into our standard Canvas Art® lineup. The result is a magnificent display that literally leaves
More news about: SKYWORTH USA
Aug 31, 2026, 12:03 ET Probably Genetic Awarded Up to $10M ARPA-H Contract to End the Rare Disease Diagnostic Odyssey with AI
novel, direct-to-patient approach. This dataset, which will integrate clinical records, patient-reported information, and biological data including DNA, will be used to train AI models to identify undiagnosed patients globally and power all stages of the drug development lifecycle from target discovery
More news about: Probably Genetic
Aug 31, 2026, 10:15 ET Oligonucleotide CDMO Market worth $11.14 billion by 2031 - Exclusive Report by MarketsandMarkets™
Oligonucleotide Synthesis Market by Offerings (Synthesis products [Consumables, Equipment], Synthesized Oligos (Type [DNA, RNA], Oligo-based Drugs (Type [ASO, siRNA), Therapy Area [Rare Diseases, Neurology, Oncology], Competition - Global Forecast to 2031
More news about: MarketsandMarkets
Aug 31, 2026, 07:00 ET BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
life-changing therapies in oncology and rare diseases. The Company's lead development asset is GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other solid tumors, for which a Phase 1/2a clinical trial was initiated in the first quarter of 2026. GLIX1 is being
More news about: BioLineRx Ltd.
Aug 31, 2026, 06:00 ET IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
chains generated by PARP during the DNA damage response, leading to persistent PARylation and impaired resolution of DNA repair complexes. Together with TOP1-payload ADCs, this unique mechanism-of-action results in sustained TOP1 cleavage complexes and the accumulation of DNA damage that delivers enhanced
More news about: IDEAYA Biosciences, Inc.
Aug 31, 2026, 05:15 ET GAC's First Off-Road Model XT80 Makes Its Overseas Debut Alongside GS7 PHEV at ADIHEX 2026
nobility, and wisdom, representing the spirit of conquering the wilderness and exploring distant horizons – a perfect match for the XT80's off-road DNA.The GS7 PHEV, positioned as a Tech-Luxury Super SUV, delivers luxury comfort, smart technology, and comprehensive safety, precisely meeting the
More news about: GAC
Aug 28, 2026, 08:00 ET BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
life-changing therapies in oncology and rare diseases. The Company's lead development asset is GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other solid tumors, for which a Phase 1/2a clinical trial was initiated in the first quarter of 2026. GLIX1 is being
More news about: BioLineRx Ltd.
Aug 28, 2026, 07:00 ET Bullfrog Spas Marks 30 Years of Innovation, Growth and Utah-Based Manufacturing
Bullfrog Spas and a testament to the people who have helped build this company," said Dan Sjoblom, CEO of Bullfrog Spas. "Innovation has been part of our DNA from the beginning. We're proud of what started here in Utah and of the talented people who continue to design, engineer, build and support our products
More news about: Bullfrog Spas
Aug 28, 2026, 00:03 ET Spoločnosti Sayari a DataExpert uzatvárajú partnerstvo, aby priniesli suverénnu umelú inteligenciu pre ekonomickú bezpečnosť vládam v celej Európe
DataExpert, jej školiaca akadémia a hlboké korene v európskych spravodajských informáciách z otvorených zdrojov (OSINT) a vyšetrovacia komunita už od prvého dňa poskytujú orgánom špecializovanú implementáciu, prispôsobené pracovné postupy a lokálnu podporu priamo v danej krajine.„Od európskych orgánov
More news about: Sayari Labs, Inc.
Aug 27, 2026, 22:44 ET Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
cancers, as well as collaborations with the Dana-Farber Cancer Institute and Mass General Brigham to evaluate cadonilimab in combination with INOVIO's DNA medicine INO-5412 in glioblastoma (GBM).Ivonescimab is currently being evaluated in more than 17 registrational Phase II/III studies, including
More news about: Akeso, Inc.
Aug 27, 2026, 20:00 ET AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
Company's proprietary Med-Oligo™ ASO platform. AHB-137 is designed to suppress hepatitis B surface antigen (HBsAg) production, inhibit viral DNA replication, and promote immune reactivation, with the goal of achieving a functional cure for CHB. AHB-137 has demonstrated promising clinical results
More news about: AusperBio Therapeutics Inc.
Aug 27, 2026, 13:12 ET Narayanan Parameswaran Named Executive Vice President for Research at RFU
embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in the areas of neuroscience, brain related diseases, inherited disorders, diabetes, obesity, and gait and balance, the
More news about: Rosalind Franklin University of Medicine and Science
Aug 27, 2026, 09:00 ET Rose BioSolutions Appoints Thomas VanCott, Ph.D., as Head of HemaCare
is purpose-built to deliver end-to-end solutions for clients on industry-leading timelines and offers manufacturing across the full suite of plasmid DNA, viral vector, and cell therapies, as well as cell supply operations. Rose Bio operates facilities in Rockville, Maryland; Memphis, Tennessee; Northridge,
More news about: Rose BioSolutions
Aug 27, 2026, 04:00 ET A HUBLOT APRESENTA O BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: DANDO INÍCIO A UMA NOVA TEMPORADA LENDÁRIA
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar o convencional, o DNA da Hublot é traduzido nos calibre Unico, Meca-10 e turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à Arte
More news about: Hublot SA
Aug 27, 2026, 04:00 ET HUBLOT SVELA IL BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: IL CALCIO D'INIZIO DI UNA NUOVA E LEGGENDARIA STAGIONE
gli Exceptional Timepiece superano le aspettative per creare segnatempo senza precedenti. Con il suo approccio dirompente che sfida le convenzioni, il DNA di Hublot è trascritto nei calibri di manifattura di Unico, Meca-10 e Tourbillon, per aggiungere un ulteriore livello di significato all'Art of Fusion.Dal
More news about: Hublot SA
Aug 27, 2026, 04:00 ET HUBLOT PRÄSENTIERT DIE BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: START IN EINE NEUE EPISCHE SAISON
Auch die in der eigenen Manufaktur entwickelten und produzierten Uhrwerke von Hublot – Unico, Meca-10 und Tourbillonkaliber – tragen die rebellische DNA in sich, die die Marke dazu antreibt, die Konventionen ein ums andere Mal herauszufordern. Damit fügen sie der Kunst der Fusion eine weitere Bedeutungsebene
More news about: Hublot SA
Aug 27, 2026, 04:00 ET HUBLOT UNVEILS THE BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: KICKING OFF A NEW LEGENDARY SEASON
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house calibers, to add another tier of meaning to the Art of Fusion.Since 2026, Hublot's
More news about: Hublot SA
Aug 27, 2026, 04:00 ET HUBLOT UNVEILS THE BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: KICKING OFF A NEW LEGENDARY SEASON
Exceptional Timepieces overwrite expectations to create unprecedented horological objects. With its disruptive approach of challenging convention, Hublot's DNA is transcribed in the Unico, Meca-10 and tourbillon in-house calibers, to add another tier of meaning to the Art of Fusion.Since 2026, Hublot's
More news about: Hublot SA
Aug 27, 2026, 04:00 ET A HUBLOT APRESENTA O BIG BANG RELOADED UEFA CHAMPIONS LEAGUE TITANIUM CERAMIC: DANDO INÍCIO A UMA NOVA TEMPORADA LENDÁRIA
Exceptional Timepieces superam todas as expectativas com criações relojoeiras sem precedentes. Com sua disruptiva abordagem de desafiar o convencional, o DNA da Hublot é traduzido nos calibre Unico, Meca-10 e turbilhão que ela mesma desenvolveu internamente, adicionando mais uma camada de significado à Arte
More news about: Hublot SA
Aug 27, 2026, 03:04 ET Silver Cross & Automobili Lamborghini Unveil Reef AL Giallo, the Final Chapter in Their 'Super Stroller' Collaboration
Limited to 500 units worldwide, Reef AL Giallo follows the brands' debut collaboration, Reef AL Arancio, translating Automobili Lamborghini's design DNA into a bold new chromatic statement. Reef AL Giallo closes out the partnership with one final expression of luxury craftsmanship and precision engineering
More news about: Silver Cross
Aug 27, 2026, 03:04 ET Silver Cross & Automobili Lamborghini Unveil Reef AL Giallo, the Final Chapter in Their 'Super Stroller' Collaboration
Limited to 500 units worldwide, Reef AL Giallo follows the brands' debut collaboration, Reef AL Arancio, translating Automobili Lamborghini's design DNA into a bold new chromatic statement. Reef AL Giallo closes out the partnership with one final expression of luxury craftsmanship and precision engineering
More news about: Silver Cross
Aug 26, 2026, 15:00 ET Greenberg Traurig Deploys the Next Generation of CoCounsel Legal
helping lead the profession in putting it to work."Innovation with guardrails Innovation is part of Greenberg Traurig's DNA and core values. The firm has long been an early adopter of transformative technology, and its approach to AI is no different: actively shaping the tools
More news about: Greenberg Traurig, LLP
Aug 26, 2026, 14:52 ET Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
hard-to-treat disease.About the PATHWAY HER2 (4B5) test and VENTANA HER2 Dual ISH DNA Probe Cocktail The PATHWAY® HER2 (4B5) Rabbit Monoclonal Primary Antibody test and VENTANA® HER2 Dual ISH DNA Probe Cocktail work together to assess HER2 status, delivering diagnostic precision
More news about: Roche
Aug 26, 2026, 10:07 ET DentalInsurance.com Releases Nationwide Research on Dental Plan Costs & Benefits
this new data resource builds on that strong foundation." Avery Smith, president of DentalInsurance.com, added, "Helping people is in our corporate DNA. We really do believe an informed consumer is the best customer."Full access to the information can be found at the website's
More news about: DentalInsurance.com